SAS-B deep dive: approvals soar in ’24 with category five medicine leading the charge by Steve Jones January 22, 2025January 22, 2025 The number of medicinal cannabis approvals through the Special Access Scheme jumped almost 40% in 2024, […]
TGA ‘exploring’ patient safety but stresses importance of ‘timely access’ to medicinal cannabis by Steve Jones January 14, 2025January 14, 2025
Defending the role of cannabis as a public and community good: the call to action in 2025 by Andrew Proudfoot January 9, 2025January 9, 2025
Medical cannabis can be life changing, let’s not lose all we have gained by Dr Nic Giummarra December 11, 2024December 11, 2024
Pastilles continue steady SAS-B growth but flower retains top spot by Steve Jones December 4, 2024December 4, 2024
Health bodies urge TGA to remove medical cannabis from SAS as ‘alarm’ grows over ‘highly potent’ THC by Steve Jones November 22, 2024November 22, 2024
NSW SAS-B approvals below annual average following crackdown by Steve Jones October 2, 2024October 2, 2024
May SAS-B approvals hold steady as THC-only product remains dominant by Steve Jones June 3, 2024June 3, 2024
Pastilles gaining in popularity as SAS-B approvals maintain strong start to 2024 by Steve Jones May 6, 2024July 16, 2024
SAS-B data highlights concerning trend towards prescribing THC for anxiety by Steve Jones October 11, 2023October 11, 2023
